Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

224
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
224
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

186
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.

Nature communications·2026
Same author

Genomic characterization of the emerging multidrug-resistant <i>Klebsiella pneumoniae</i> ST6668 clone in northern Italy, 2020-2025.

Microbiology spectrum·2026
Same author

Diagnostic Assays for TB Disease and Drug Resistance Detection-Advances and Latest WHO Recommendations.

Cold Spring Harbor perspectives in medicine·2026
Same author

A cartridge-based assay for improved detection of multidrug-resistant <i>Mycobacterium tuberculosis</i> directly from sputum.

Journal of clinical microbiology·2026
Same author

In-home molecular testing of tongue swabs and sputum to inform household-level screening with diagnostic escalation strategies for tuberculosis contact investigation: a prospective cohort study in South Africa.

medRxiv : the preprint server for health sciences·2026
Same author

Acceptability of tongue swabs for tuberculosis screening in migrant settings in northern Italy: A qualitative study.

PLOS global public health·2026

Related Experiment Video

Updated: Aug 11, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.2K

Designing molecular diagnostics for current tuberculosis drug regimens.

Sophia B Georghiou1, Margaretha de Vos1, Kavindhran Velen1

  • 1FIND, the Global Alliance for Diagnostics, Geneva, Switzerland.

Emerging Microbes & Infections
|February 8, 2023
PubMed
Summary

Rapid molecular diagnostics are crucial for tuberculosis treatment. Current gaps hinder drug susceptibility testing for key drugs, impacting treatment effectiveness and resistance management for tuberculosis and drug-resistant tuberculosis.

Keywords:
Bedaquilinelinezolidmolecular diagnosticsnitroimidazolespyrazinamide

More Related Videos

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.8K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.7K

Related Experiment Videos

Last Updated: Aug 11, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.2K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.8K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.7K

Area of Science:

  • Microbiology and Infectious Diseases
  • Molecular Diagnostics
  • Antimicrobial Resistance

Background:

  • Drug development for tuberculosis (TB) outpaces diagnostic capabilities, particularly for novel and repurposed drugs.
  • Existing molecular diagnostics lack rapid drug susceptibility testing for critical TB drugs like linezolid, bedaquiline, and pyrazinamide.
  • This diagnostic gap compromises the effectiveness of current and emerging TB treatment regimens.

Purpose of the Study:

  • To identify critical diagnostic gaps in molecular testing for tuberculosis drug resistance.
  • To evaluate potential gene targets for rapid molecular assays and sequencing for novel TB drugs.
  • To propose design priorities for next-generation molecular diagnostics to guide TB treatment.

Main Methods:

  • Review of current World Health Organization (WHO) TB treatment guidelines and emerging regimens.
  • Analysis of existing molecular diagnostic technologies and their feasibility for detecting resistance mutations.
  • Identification of key gene targets for novel and repurposed anti-tuberculosis compounds.

Main Results:

  • Significant diagnostic gaps exist for rapid drug susceptibility testing of key TB drugs.
  • Feasibility of mutation detection varies across existing technologies for novel drug resistance markers.
  • Prioritization of specific gene targets is needed for next-generation molecular assays.

Conclusions:

  • Development of rapid molecular diagnostics must parallel drug development to ensure treatment longevity.
  • Next-generation molecular assays are essential for accurate patient triage and effective TB regimen selection.
  • Prioritizing development and uptake of molecular assays, including sequencing, is crucial to combat TB drug resistance and achieve End TB targets.